MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.aed.2025.09.010

Медицинская библиотека · AACE endocrinology and diabetes · 2025

Reversible Severe Hyperglycemia Without Ketoacidosis After Initiation of Bictegravir-containing Antiretroviral Therapy.

Aurora John, Grossman Katlyn, Hudson Sydney, Kogelman Laura, Pittas Anastassios G

Клинический случайСтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Bictegravir (BIC), a second-generation integrase strand transfer inhibitor, may induce acute hyperglycemia in patients with metabolic risk factors, though this was not reported in clinical trials. We describe a patient who developed severe hyperglycemia shortly after starting a BIC-containing antiretroviral therapy (ART).

CASE REPORT: A 36-year-old patient with virologically suppressed HIV, obesity, and prediabetes developed severe hyperglycemia, HbA1c 12.8% and nonfasting blood glucose of 685 mg/dL, without ketoacidosis within 2 months after switching to a BIC-containing ART requiring hospitalization and insulin therapy. Glycemia improved after discontinuation of BIC, suggesting a direct cause and effect with BIC. There were no significant changes in body weight, HIV viral load, or CD4+ T-cell count during this period, as well as a negative evaluation for secondary causes of hyperglycemia.

DISCUSSION: Acute hyperglycemia from BIC was not associated with weight changes and was reversible with no long-term effects on pancreatic beta-cell function. Incorporating metabolic monitoring (glycemia, weight, and lipid profile) and patient education for BIC into clinical practice, and utilizing a multidisciplinary team, can reduce the risk of acute hyperglycemia and glycemia-related hospitalization.

CONCLUSION

Patients starting a BIC-containing ART who have a history of obesity and/or dysglycemia should be educated and monitored for risk of developing acute hyperglycemia, which can be reversed upon BIC discontinuation.

Для цитирования: Aurora John, Grossman Katlyn, Hudson Sydney, Kogelman Laura, Pittas Anastassios G. Reversible Severe Hyperglycemia Without Ketoacidosis After Initiation of Bictegravir-containing Antiretroviral Therapy.. AACE endocrinology and diabetes. 2025. DOI: 10.1016/j.aed.2025.09.010.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.